These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 10088996)

  • 1. Neuropeptide Y: emerging evidence for a functional role in seizure modulation.
    Vezzani A; Sperk G; Colmers WF
    Trends Neurosci; 1999 Jan; 22(1):25-30. PubMed ID: 10088996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple receptors for neuropeptide Y in the hippocampus: putative roles in seizures and cognition.
    Redrobe JP; Dumont Y; St-Pierre JA; Quirion R
    Brain Res; 1999 Nov; 848(1-2):153-66. PubMed ID: 10612707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential actions of NPY on seizure modulation via Y1 and Y2 receptors: evidence from receptor knockout mice.
    Lin EJ; Young D; Baer K; Herzog H; During MJ
    Epilepsia; 2006 Apr; 47(4):773-80. PubMed ID: 16650144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plastic changes in neuropeptide Y receptor subtypes in experimental models of limbic seizures.
    Vezzani A; Moneta D; Mulé F; Ravizza T; Gobbi M; French-Mullen J
    Epilepsia; 2000; 41 Suppl 6():S115-21. PubMed ID: 10999532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous neuropeptide Y prevents recurrence of experimental febrile seizures by increasing seizure threshold.
    Dubé C; Brunson KL; Eghbal-Ahmadi M; Gonzalez-Vega R; Baram TZ
    J Mol Neurosci; 2005; 25(3):275-84. PubMed ID: 15800380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the Y5 neuropeptide Y receptor in limbic seizures.
    Marsh DJ; Baraban SC; Hollopeter G; Palmiter RD
    Proc Natl Acad Sci U S A; 1999 Nov; 96(23):13518-23. PubMed ID: 10557353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptide Y and epilepsy: varying effects according to seizure type and receptor activation.
    Reibel S; Nadi S; Benmaamar R; Larmet Y; Carnahan J; Marescaux C; Depaulis A
    Peptides; 2001 Mar; 22(3):529-39. PubMed ID: 11287111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical potentials of neuropeptide Y family of hormones.
    Balasubramaniam A
    Am J Surg; 2002 Apr; 183(4):430-4. PubMed ID: 11975932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptide Y-stimulated [(35) S]GTPγs functional binding is reduced in the hippocampus after kainate-induced seizures in mice.
    Elbrønd-Bek H; Olling JD; Gøtzsche CR; Waterfield A; Wörtwein G; Woldbye DP
    Synapse; 2014 Oct; 68(10):427-36. PubMed ID: 24985894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The regulation of veratridine-stimulated electrogenic ion transport in mouse colon by neuropeptide Y (NPY), Y1 and Y2 receptors.
    Hyland NP; Cox HM
    Br J Pharmacol; 2005 Nov; 146(5):712-22. PubMed ID: 16100526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y.
    Kask A; Harro J; von Hörsten S; Redrobe JP; Dumont Y; Quirion R
    Neurosci Biobehav Rev; 2002 May; 26(3):259-83. PubMed ID: 12034130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous control of hippocampal epileptogenesis: a molecular cascade involving brain-derived neurotrophic factor and neuropeptide Y.
    Reibel S; Larmet Y; Carnahan J; Marescaux C; Depaulis A
    Epilepsia; 2000; 41 Suppl 6():S127-33. PubMed ID: 10999534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropeptide Y: potential role in recurrent developmental seizures.
    Dubé C
    Peptides; 2007 Feb; 28(2):441-6. PubMed ID: 17196709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypothalamic circuitry of neuropeptide Y regulation of neuroendocrine function and food intake via the Y5 receptor subtype.
    Campbell RE; ffrench-Mullen JM; Cowley MA; Smith MS; Grove KL
    Neuroendocrinology; 2001 Aug; 74(2):106-19. PubMed ID: 11474218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptide Y as an endogenous antiepileptic, neuroprotective and pro-neurogenic peptide.
    Xapelli S; Agasse F; Ferreira R; Silva AP; Malva JO
    Recent Pat CNS Drug Discov; 2006 Nov; 1(3):315-24. PubMed ID: 18221213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropeptide Y: some viewpoints on a multifaceted peptide in the normal and diseased nervous system.
    Hökfelt T; Broberger C; Zhang X; Diez M; Kopp J; Xu Z; Landry M; Bao L; Schalling M; Koistinaho J; DeArmond SJ; Prusiner S; Gong J; Walsh JH
    Brain Res Brain Res Rev; 1998 May; 26(2-3):154-66. PubMed ID: 9651513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide Y and its receptors as potential therapeutic drug targets.
    Silva AP; Cavadas C; Grouzmann E
    Clin Chim Acta; 2002 Dec; 326(1-2):3-25. PubMed ID: 12417094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anti-epileptic actions of neuropeptide Y in the hippocampus are mediated by Y and not Y receptors.
    El Bahh B; Balosso S; Hamilton T; Herzog H; Beck-Sickinger AG; Sperk G; Gehlert DR; Vezzani A; Colmers WF
    Eur J Neurosci; 2005 Sep; 22(6):1417-30. PubMed ID: 16190896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptide Y and limbic seizures.
    Baraban SC
    Rev Neurosci; 1998; 9(2):117-28. PubMed ID: 9711903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic comparison of seizure control by norepinephrine and neuropeptide Y.
    Weinshenker D; Szot P; Miller NS; Rust NC; Hohmann JG; Pyati U; White SS; Palmiter RD
    J Neurosci; 2001 Oct; 21(19):7764-9. PubMed ID: 11567066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.